RE: Sure ..9 Oct 2017 17:54
From the FT tearsheet on OXB. Below is good research imo, I see the share as a long term accumulate and hold. Yes there will be ups and downs driven by news and speculation but drugs and delivery systems take time to develop.
"The 4 analysts offering 12 month price targets for Oxford BioMedica plc have a median target of 13.00, with a high estimate of 21.00 and a low estimate of 10.20. The median estimate represents a 43.01% increase from the last price of 9.09."